Free tool
FAERS Monitor: Epivir
Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020596 or its brand name (Epivir, Lamivudine). Reports on generic versions are filed under their own applications.
Reports
30,839
Serious
29,623
96% of reports
Hospitalization
9,361
Death reported
4,112
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- foetal exposure during pregnancy2,040
- drug resistance1,960
- virologic failure1,960
- drug interaction1,871
- pathogen resistance1,774
- viral mutation identified1,671
- depression1,343
- pyrexia1,279
- drug ineffective1,165
- anaemia1,126
- pain1,122
- nausea1,079
- treatment failure1,028
- vomiting1,023
- anxiety987
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,143 |
| 2005 | 1,218 |
| 2006 | 1,265 |
| 2007 | 1,049 |
| 2008 | 1,114 |
| 2009 | 1,084 |
| 2010 | 763 |
| 2011 | 671 |
| 2012 | 757 |
| 2013 | 670 |
| 2014 | 805 |
| 2015 | 1,613 |
| 2016 | 2,262 |
| 2017 | 2,126 |
| 2018 | 2,122 |
| 2019 | 2,247 |
| 2020 | 2,541 |
| 2021 | 1,842 |
| 2022 | 1,853 |
| 2023 | 1,697 |
| 2024 | 864 |
| 2025 | 718 |
| 2026 | 401 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,023,320 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| viral mutation identifiedSignal | 1,671 | 565.1 | 530.1 | 514,230 |
| virologic failureSignal | 1,960 | 390.3 | 369.7 | 483,893 |
| pathogen resistanceSignal | 1,774 | 164.5 | 156.4 | 232,257 |
| drug resistanceSignal | 1,960 | 56.3 | 53.8 | 98,330 |
| foetal exposure during pregnancySignal | 2,040 | 17.5 | 16.8 | 31,106 |
| treatment failureSignal | 1,028 | 8.6 | 8.1 | 6,795 |
| drug interactionSignal | 1,871 | 8.1 | 7.8 | 11,638 |
| anaemiaSignal | 1,126 | 4.0 | 3.8 | 2,586 |
| depressionSignal | 1,343 | 4.0 | 3.8 | 3,089 |
| pyrexiaSignal | 1,279 | 2.5 | 2.4 | 1,194 |
| anxietySignal | 987 | 2.4 | 2.2 | 788 |
| vomiting | 1,023 | 1.5 | 1.4 | 165 |
| pain | 1,122 | 1.2 | 1.2 | 56 |
| nausea | 1,079 | 0.9 | 0.9 | 6 |
| drug ineffective | 1,165 | 0.6 | 0.6 | 325 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.